Elena Cerrillo1, Belén Beltrán, Salvador Pous, Ana Echarri, Jose Carlos Gallego, Marisa Iborra, Jose Pamies, Pilar Nos. 1. *Gastroenterology Department, La Fe University and Polytechnic Hospital, Valencia, Spain; †Instituto de Investigación Sanitaria Hospital La Fe, Valencia, Spain; ‡Centro de investigación biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Barcelona, Spain; §General Surgery Department, La Fe University and Polytechnic Hospital, Valencia, Spain; ‖Gastroenterology Department, and ¶Radiology Department, University Hospital, Ferrol, Spain; and **Radiology Department, La Fe University and Polytechnic Hospital, Valencia, Spain.
Abstract
BACKGROUND: Magnetic resonance enterography (MRE) is an effective method of assessing small bowel Crohn's disease (CD). Fecal calprotectin (FC) correlates well with endoscopic disease activity. We aimed to evaluate the correlation between FC and disease activity according to MRE and surgical pathology in small bowel CD. METHODS: One hundred twenty consecutive patients with ileal CD who underwent MRE assessment were included. Clinical data, C-reactive protein and FC, radiological and histological variables were obtained. Clinical activity was evaluated by the Harvey-Bradshaw Index and FC by enzyme-linked immunosorbent assay. MRE activity was assessed by means of the Magnetic Resonance Index of Activity score. Chiorean's score was used to grade pathological inflammation in surgical specimens. RESULTS: Seventy-five patients (62.5%) were in clinical remission (Harvey-Bradshaw Index < 5) and 45 (37.5%) had active disease (Harvey-Bradshaw Index ≥ 5). The Magnetic Resonance Index of Activity score was significantly associated with FC levels (P < 0.01), with a moderate overall correlation (Spearman's r = 0.56, P < 0.001). FC reflected MRE inflammatory activity with an area under the receiver operating characteristic curve of 0.914 (confidence interval, 0.849-0.958; P < 0.001). A cutoff value of 166.50 μg/g had 90% sensitivity, 74% specificity, 89% positive predictive value, and 76% negative predictive value for diagnosis of inflammation. Twenty-eight of 120 patients were operated. Surgical pathology showed a good agreement with FC for moderate (P = 0.03) and severe (P = 0.01) Chiorean's index. No relationship was detected for C-reactive protein. CONCLUSIONS: FC correlates with the degree of MRE inflammatory activity and with surgical pathology damage in ileal CD. Thus, FC could be a surrogate marker of disease control used to select patients for MRE assessment and therapeutic adjustment.
BACKGROUND: Magnetic resonance enterography (MRE) is an effective method of assessing small bowel Crohn's disease (CD). Fecal calprotectin (FC) correlates well with endoscopic disease activity. We aimed to evaluate the correlation between FC and disease activity according to MRE and surgical pathology in small bowel CD. METHODS: One hundred twenty consecutive patients with ileal CD who underwent MRE assessment were included. Clinical data, C-reactive protein and FC, radiological and histological variables were obtained. Clinical activity was evaluated by the Harvey-Bradshaw Index and FC by enzyme-linked immunosorbent assay. MRE activity was assessed by means of the Magnetic Resonance Index of Activity score. Chiorean's score was used to grade pathological inflammation in surgical specimens. RESULTS: Seventy-five patients (62.5%) were in clinical remission (Harvey-Bradshaw Index < 5) and 45 (37.5%) had active disease (Harvey-Bradshaw Index ≥ 5). The Magnetic Resonance Index of Activity score was significantly associated with FC levels (P < 0.01), with a moderate overall correlation (Spearman's r = 0.56, P < 0.001). FC reflected MRE inflammatory activity with an area under the receiver operating characteristic curve of 0.914 (confidence interval, 0.849-0.958; P < 0.001). A cutoff value of 166.50 μg/g had 90% sensitivity, 74% specificity, 89% positive predictive value, and 76% negative predictive value for diagnosis of inflammation. Twenty-eight of 120 patients were operated. Surgical pathology showed a good agreement with FC for moderate (P = 0.03) and severe (P = 0.01) Chiorean's index. No relationship was detected for C-reactive protein. CONCLUSIONS:FC correlates with the degree of MRE inflammatory activity and with surgical pathology damage in ileal CD. Thus, FC could be a surrogate marker of disease control used to select patients for MRE assessment and therapeutic adjustment.
Authors: James Turvill; Lisa Rook; Maxine Rawle; Gerry Robins; Simon Smale; Prashant Kant; Anne Phillips Journal: Frontline Gastroenterol Date: 2017-01-30
Authors: Birgit Adam; Michael Koldehoff; Markus Ditschkowski; Tanja Gromke; Michal Hlinka; Rudolf Trenschel; Lambros Kordeals; Nina K Steckel; Dietrich W Beelen; Tobias Liebregts Journal: Dig Dis Sci Date: 2016-03-19 Impact factor: 3.199
Authors: David J Gracie; Christopher J M Williams; Ruchit Sood; Saqib Mumtaz; M Hassan Bholah; P John Hamlin; Alexander C Ford Journal: Am J Gastroenterol Date: 2016-03-22 Impact factor: 10.864
Authors: Parambir S Dulai; Siddharth Singh; Niels Vande Casteele; Brigid S Boland; Jesus Rivera-Nieves; Peter B Ernst; Lars Eckmann; Kim E Barrett; John T Chang; William J Sandborn Journal: Clin Gastroenterol Hepatol Date: 2019-04-19 Impact factor: 13.576
Authors: Yannick Derwa; Christopher J M Williams; Ruchit Sood; Saqib Mumtaz; M Hassan Bholah; Christian P Selinger; P John Hamlin; Alexander C Ford; David J Gracie Journal: Therap Adv Gastroenterol Date: 2018-01-18 Impact factor: 4.409